Interestingly, a significant decrease in the activation of PI3K-Akt pathway has been observed in the SNpc of PD patients45 and a decline in NRF2 expression has been detected in AD and PD patients with age-dependent cognitive loss46–48. This evidence concerns the gene AKT1 and Alzheimer disease.